quinacrine has been researched along with vasoactive intestinal peptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kendall, DA; Robinson, JP | 1 |
| Magistretti, PJ; Martin, JL | 1 |
| Said, SI; Trotz, ME | 1 |
3 other study(ies) available for quinacrine and vasoactive intestinal peptide
| Article | Year |
|---|---|
No role for phospholipase A2 and protein kinase C in the potentiation by alpha-adrenoceptors of beta-adrenoceptor-mediated cyclic AMP formation in rat brain.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Brain; Cyclic AMP; Cyclooxygenase Inhibitors; Lipoxygenase Inhibitors; Male; Melitten; Phospholipases; Phospholipases A; Phospholipases A2; Protein Kinase C; Quinacrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoactive Intestinal Peptide | 1989 |
Release of vasoactive intestinal peptide in mouse cerebral cortex: evidence for a role of arachidonic acid metabolites.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cerebral Cortex; Chromatography, High Pressure Liquid; Lipoxygenase Inhibitors; Male; Melitten; Mice; Quinacrine; Tetrodotoxin; Vasoactive Intestinal Peptide | 1989 |
Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Elapid Venoms; Escherichia coli; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Pancreas; Peptides; Phospholipases A; Phospholipases A2; Phospholipids; Quinacrine; Serum Albumin, Bovine; Vasoactive Intestinal Peptide | 1993 |